Loading...
Amoxycillin 200 mg +Potassium Clavulanic 28.5 mg+ Lactic Acid Bacillus 60 Million Spores
A dual-action antibacterial and probiotic formula designed to treat pediatric infections while protecting the delicate balance of the gut microbiome. OMILAR-CV LB combines a broad-spectrum antibiotic and a resistance-breaking agent with Lactic Acid Bacillus to prevent antibiotic-associated diarrhea and ensure a comfortable recovery.
A dual-action antibacterial and probiotic formula designed to treat pediatric infections while protecting the delicate balance of the gut microbiome. OMILAR-CV LB combines a broad-spectrum antibiotic and a resistance-breaking agent with Lactic Acid Bacillus to prevent antibiotic-associated diarrhea and ensure a comfortable recovery.
Amoxycillin 200mg is a broad-spectrum penicillin that destroys bacteria by inhibiting cell wall synthesis. It is highly effective against a wide range of pathogens responsible for common childhood infections, providing a rapid onset of action to clear the body of harmful bacteria.
Clavulanic Acid 28.5mg acts as a powerful beta-lactamase inhibitor. Many bacteria produce enzymes that neutralize antibiotics; Clavulanic Acid binds to these enzymes, acting as a sterile shield that allows Amoxycillin to successfully eliminate resistant strains that would otherwise survive standard treatment.
Antibiotics can often disrupt the natural "good" bacteria in the digestive tract, leading to stomach upset and diarrhea. The inclusion of Lactic Acid Bacillus (60 Million Spores) helps replenish the gut flora during the course of treatment, maintaining a healthy microbial balance and improving overall digestion.
Lactic Acid Bacillus is a resilient probiotic that survives stomach acid to reach the intestines. By restoring the intestinal environment, it significantly reduces the incidence of diarrhea and abdominal cramping, which are the most common side effects of antibiotic therapy in pediatric patients.
OMILAR-CV LB is a gold-standard choice for treating various infections, including those of the ear, nose, throat, and respiratory tract. The combination ensures that even if the infection is caused by resistant organisms like H. influenzae or Moraxella, the treatment remains highly effective.
By addressing both the infection and the potential side effects in a single dry syrup formulation, OMILAR-CV LB improves patient compliance. Parents find it easier to administer, and children experience fewer gastrointestinal complications, leading to a smoother and faster recovery process.
Indication Acute Otitis Media (Middle Ear Infection), Recurrent Tonsillitis and Sinusitis, Lower Respiratory Tract Infections (Bronchitis), Skin and Soft Tissue Infections, Urinary Tract Infections, Prevention of Antibiotic-Induced Gastric Upset.
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
